Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015, Article ID 915486, 10 pages
http://dx.doi.org/10.1155/2015/915486
Research Article

Increased DNA Dicarbonyl Glycation and Oxidation Markers in Patients with Type 2 Diabetes and Link to Diabetic Nephropathy

1Warwick Medical School, Clinical Sciences Research Laboratories, University of Warwick, University Hospital, Coventry CV2 2DX, UK
2Human Nutrition & Metabolism Research and Training Center Graz, Institute of Molecular Biosciences, Karl Franzens University, 8010 Graz, Austria
3Clinical Division of Nephrology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria
4Clinical Division of Endocrinology and Nuclear Medicine, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria
5Warwick Systems Biology Centre, Senate House, University of Warwick, Coventry CV4 7AL, UK

Received 1 January 2015; Revised 14 March 2015; Accepted 23 March 2015

Academic Editor: Patrizio Tatti

Copyright © 2015 Sahar Waris et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. C. McLellan, P. J. Thornalley, J. Benn, and P. H. Sonksen, “Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications,” Clinical Science, vol. 87, no. 1, pp. 21–29, 1994. View at Google Scholar · View at Scopus
  2. N. Rabbani and P. J. Thornalley, “Dicarbonyls (glyoxal, methylglyoxal, and 3-deoxyglucosone),” in Uremic Toxins, pp. 177–192, John Wiley & Sons, 2012. View at Google Scholar
  3. J. W. Baynes, “Role of oxidative stress in development of complications in diabetes,” Diabetes, vol. 40, no. 4, pp. 405–412, 1991. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Dandona, K. Thusu, S. Cook et al., “Oxidative damage to DNA in diabetes mellitus,” The Lancet, vol. 347, no. 8999, pp. 444–445, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. P. J. Thornalley, S. Waris, T. Fleming et al., “Imidazopurinones are markers of physiological genomic damage linked to DNA instability and glyoxalase 1-associated tumour multidrug resistance,” Nucleic Acids Research, vol. 38, no. 16, Article ID gkq306, pp. 5432–5442, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Xue, N. Rabbani, and P. J. Thornalley, “Glyoxalase in ageing,” Seminars in Cell and Developmental Biology, vol. 22, no. 3, pp. 293–301, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Bierhaus, T. Fleming, S. Stoyanov et al., “Methylglyoxal modification of Nav 1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy,” Nature Medicine, vol. 18, no. 6, pp. 926–933, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Palsamy and S. Subramanian, “Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling,” Biochimica et Biophysica Acta, vol. 1812, no. 7, pp. 719–731, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. M. T. Barati, M. L. Merchant, A. B. Kain, A. W. Jevans, K. R. McLeish, and J. B. Klein, “Proteomic analysis defines altered cellular redox pathways and advanced glycation end-product metabolism in glomeruli of db/db diabetic mice,” American Journal of Physiology: Renal Physiology, vol. 293, no. 4, pp. F1157–F1165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Karachalias, R. Babaei-Jadidi, N. Rabbani, and P. J. Thornalley, “Increased protein damage in renal glomeruli, retina, nerve, plasma and urine and its prevention by thiamine and benfotiamine therapy in a rat model of diabetes,” Diabetologia, vol. 53, no. 7, pp. 1506–1516, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Hinokio, S. Suzuki, M. Hirai, M. Chiba, A. Hirai, and T. Toyota, “Oxidative DNA damage in diabetes mellitus: its association with diabetic complications,” Diabetologia, vol. 42, no. 8, pp. 995–998, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Hinokio, S. Suzuki, M. Hirai, C. Suzuki, M. Suzuki, and T. Toyota, “Urinary excretion of 8-oxo-7, 8-dihydro-2′-deoxyguanosine as a predictor of the development of diabetic nephropathy,” Diabetologia, vol. 45, no. 6, pp. 877–882, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Seidel and M. Pischetsrieder, “DNA-glycation leads to depurination by the loss of N2-carboxyethylguanine in vitro,” Cellular and Molecular Biology, vol. 44, no. 7, pp. 1165–1170, 1998. View at Google Scholar · View at Scopus
  14. F. Giacco, X. Du, V. D. D'Agati et al., “Knockdown of glyoxalase 1 mimics diabetic nephropathy in nondiabetic mice,” Diabetes, vol. 63, no. 1, pp. 291–299, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Rabbani and P. J. Thornalley, “The critical role of methylglyoxal and glyoxalase 1 in diabetic nephropathy,” Diabetes, vol. 63, no. 1, pp. 50–52, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. C. E. Vaca, J. L. Fang, M. Conradi, and S.-M. Hou, “Development of a 32P-postlabelling method for the analysis of 2′-deoxyguanosine-3′-monophosphate and DNA adducts of methylglyoxal,” Carcinogenesis, vol. 15, no. 9, pp. 1887–1894, 1994. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Li, S. Nakamura, S. Miyazaki et al., “N2-carboxyethyl-2′-deoxyguanosine, a DNA glycation marker, in kidneys and aortas of diabetic and uremic patients,” Kidney International, vol. 69, no. 2, pp. 388–392, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. S. Cooke, R. Olinski, S. Loft, and European Standards Committee on Urinary Lesion, “Measurement and meaning of oxidatively modified DNA lesions in urine,” Cancer Epidemiol Biomarkers Prevention, vol. 17, no. 1, pp. 3–14, 2008. View at Google Scholar
  19. K. Rossing, H. Mischak, M. Dakna et al., “Urinary proteomics in diabetes and CKD,” Journal of the American Society of Nephrology, vol. 19, no. 7, pp. 1283–1290, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Rock, B. M. Winklhofer-Roob, J. Ribalta et al., “Vitamin A, vitamin E and carotenoid status and metabolism during ageing: functional and nutritional consequences (Vitage Project),” Nutrition, Metabolism and Cardiovascular Diseases, vol. 11, no. 4, supplement, pp. 70–73, 2001. View at Google Scholar · View at Scopus
  21. American-Diabetes-Association, “Standards of Medical Care in Diabetes—2014,” Diabetes Care, vol. 37, supplement 1, pp. S14–S80, 2013. View at Publisher · View at Google Scholar
  22. N. Rabbani and P. J. Thornalley, “Dicarbonyl stress in cell and tissue dysfunction contributing to ageing and disease,” Biochemical and Biophysical Research Communications, vol. 458, no. 2, pp. 221–226, 2015. View at Publisher · View at Google Scholar
  23. P. J. Thornalley, “Dicarbonyl intermediates in the Maillard reaction,” Annals of the New York Academy of Sciences, vol. 1043, pp. 111–117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Iliadis, T. Didangelos, A. Ntemka et al., “Glomerular filtration rate estimation in patients with type 2 diabetes: creatinine- or cystatin C-based equations?” Diabetologia, vol. 54, no. 12, pp. 2987–2994, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Urrechaga, E. Bereciartua, E. Crespo, and C. Izcara, “Evaluation of AdamsTM A1C Menarini HA-8180 HPLC analyser for HbA1c determination,” Clinical Chemistry and Laboratory Medicine, vol. 49, p. S406, 2011. View at Google Scholar
  26. M.-A. Gall, P. Hougaard, K. Borch-Johnsen, and H.-H. Parving, “Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study,” British Medical Journal, vol. 314, no. 7083, pp. 783–788, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Murata-Kamiya, H. Kamiya, H. Kaji, and H. Kasai, “Glyoxal, a major product of DNA oxidation, induces mutations at G:C sites on a shuttle vector plasmid replicated in mammalian cells,” Nucleic Acids Research, vol. 25, no. 10, pp. 1897–1902, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Murata-Kamiya, H. Kamiya, H. Kaji, and H. Kasai, “Methylglyoxal induces G:C to C:G and G:C to T:A transversions in the supF gene on a shuttle vector plasmid replicated in mammalian cells,” Mutation Research, vol. 468, no. 2, pp. 173–182, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. E. A. Abordo, H. S. Minhas, and P. J. Thornalley, “Accumulation of α-oxoaldehydes during oxidative stress: a role in cytotoxicity,” Biochemical Pharmacology, vol. 58, no. 4, pp. 641–648, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. T. K. Shires, J. Tresnak, M. Kaminsky, S. L. Herzog, and B. Truc-Pham, “DNA modification in vivo by derivatives of glucose: enhancement by glutathione depletion,” The FASEB Journal, vol. 4, no. 15, pp. 3340–3346, 1990. View at Google Scholar · View at Scopus
  31. M. Lorenzi, D. F. Montisano, S. Toledo, and A. Barrieux, “High glucose induces DNA damage in cultured human endothelial cells,” The Journal of Clinical Investigation, vol. 77, no. 1, pp. 322–325, 1986. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Lorenzi, D. F. Montisano, S. Toledo, and H.-C. H. Wong, “Increased single strand breaks in DNA of lymphocytes from diabetic subjects,” Journal of Clinical Investigation, vol. 79, no. 2, pp. 653–656, 1987. View at Publisher · View at Google Scholar · View at Scopus
  33. R. de Bont and N. van Larebeke, “Endogenous DNA damage in humans: a review of quantitative data,” Mutagenesis, vol. 19, no. 3, pp. 169–185, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Synold, B. Xi, G. E. Wuenschell et al., “Advanced glycation end products of DNA: quantification of N 2-(1-carboxyethyl)-2′-deoxyguanosine in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry,” Chemical Research in Toxicology, vol. 21, no. 11, pp. 2148–2155, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Brownlee, “Biochemistry and molecular cell biology of diabetic complications,” Nature, vol. 414, no. 6865, pp. 813–820, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. N. Rabbani, A. Adaikalakoteswari, K. Rossing et al., “Effect of Irbesartan treatment on plasma and urinary markers of protein damage in patients with type 2 diabetes and microalbuminuria,” Amino Acids, vol. 42, no. 5, pp. 1627–1639, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Broedbaek, V. Siersma, T. Henriksen et al., “Association between urinary markers of nucleic acid oxidation and mortality in type 2 diabetes: a population-based cohort study,” Diabetes Care, vol. 36, no. 3, pp. 669–676, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Broedbaek, A. Weimann, E. S. Stovgaard, and H. E. Poulsen, “Urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine as a biomarker in type 2 diabetes,” Free Radical Biology and Medicine, vol. 51, no. 8, pp. 1473–1479, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. M. S. Cooke, R. Singh, G. K. Hall et al., “Evaluation of enzyme-linked immunosorbent assay and liquid chromatography-tandem mass spectrometry methodology for the analysis of 8-oxo-7,8-dihydro-2′-deoxyguanosine in saliva and urine,” Free Radical Biology and Medicine, vol. 41, no. 12, pp. 1829–1836, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Barregard, P. Møller, T. Henriksen et al., “Human and methodological sources of variability in the measurement of urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine,” Antioxidants and Redox Signaling, vol. 18, no. 18, pp. 2377–2391, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Broedbaek, R. Ribel-Madsen, T. Henriksen et al., “Genetic and environmental influences on oxidative damage assessed in elderly Danish twins,” Free Radical Biology and Medicine, vol. 50, no. 11, pp. 1488–1491, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Broedbaek, T. Henriksen, A. Weimann et al., “Long-term effects of Irbesartan treatment and smoking on nucleic acid oxidation in patients with type 2 diabetes and microalbuminuria: an irbesartan in patients with type 2 diabetes and microalbuminuria (IRMA 2) substudy,” Diabetes Care, vol. 34, no. 5, pp. 1192–1198, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Schneider, G. Thoss, C. Hübner-Parajsz, R. Kientsch-Engel, P. Stahl, and M. Pischetsrieder, “Determination of glycated nucleobases in human urine by a new monoclonal antibody specific for N2-carboxyethyl-2′-deoxyguanosine,” Chemical Research in Toxicology, vol. 17, no. 10, pp. 1385–1390, 2004. View at Publisher · View at Google Scholar · View at Scopus